NBTY brings gummy format to Ester-C offering
RONKONKOMA, N.Y. – NBTY on Tuesday launched Ester-C Immune Charge Gummies to help busy families get 100% of the daily value of the patented Ester-C formula.
Ester-C is calcium ascorbate, which is formulated to contain the same metabolites the body produces that help enhance the retention of vitamin C by the white blood cells – a vital component of the immune system.
"With families more on-the-go than ever, we looked to introduce new delivery forms to the Ester-C portfolio, like gummies, which make it convenient for families to support their immune health anytime, anywhere," said John Frame, VP Ester-C. "We're excited to launch new Ester-C Immune Charge Gummies because the benefits of the patented Ester-C formula can now be experienced by the whole family, whether it be those heading off to school on the bus or grabbing the train to work."
CVS/pharmacy brings hearing, optical services in-store
WOONSOCKET, R.I. — CVS Health on Monday announced that it is opening Hearing Centers in seven CVS/pharmacy stores in the Dallas and Cleveland markets and will be providing optical services at CVS/pharmacy in five store locations around the Baltimore/Washington, D.C. market.
“Hearing and optical services are a great fit with the existing health offerings in our stores, including industry-leading pharmacy products and services, our MinuteClinic walk-in medical clinics and a comprehensive smoking cessation program,” said Andrew Sussman, president of CVS/minuteclinic and EVP and associate chief medical officer of CVS Health. “By expanding our retail health offerings into vision and hearing services, we are providing customers a convenient, single destination on their path to better health.”
“Over the past year, we have eliminated tobacco products from all of our stores, added healthy food options, and created a stronger connection between health and beauty,” said Judy Sansone, SVP front store business and chief merchant of CVS Health. “Now, by taking these first steps into providing hearing and optical services, we continue to evolve our retail locations into a leading destination for convenient and accessible health services.”
The Hearing Centers at CVS/pharmacy, which will be open Tuesdays to Saturdays, are staffed by licensed audiologists and hearing instrument specialists who are able to assess hearing needs using computerized equipment in the centers’ soundproof booths. The centers will offer a variety of hearing aid products and custom ear plugs, as well as provide services such as free hearing screenings and free in-store hearing checks and cleanings. The Hearing Centers will also offer innovative noise simulation testing to demonstrate to patients the improvements that hearing aids can provide during different life experiences. Many insurance plans will be accepted for the hearing services available.
Experts say it takes an average of seven years for consumers to seek help from a professional for their hearing loss.The hearing services offered at CVS/pharmacy will help increase awareness and access for those with hearing needs and provide the opportunity to improve their quality of life by addressing their hearing needs sooner.
Optical service at CVS/pharmacy will be available seven days a week later this fall at select locations around the Baltimore/Washington, D.C. market. Services will include comprehensive eye exams by an optometrist three days a week for both walk-ins and appointments; prescriptions for glasses and contact lenses; access to more than 600 styles of frames and sunglasses from fashionable, popular brands for women, men and children; and free cleanings and adjustments. Many insurance plans will be accepted.
All eyeglasses will have a 90-day total-satisfaction guarantee, and can be returned for any reason during this period for a full refund. Glasses purchased for children up to age 14 will be covered by a one-year guarantee.
Perrigo and Flamel partner on bringing new OTC format to market
DUBLIN – Perrigo and Flamel Technologies announced Monday that they have entered into an exclusive licensing agreement for LiquiTime extended release suspension. The technology will be utilized in the development of a portfolio of extended release suspension products intended for the U.S. OTC marketplace.
"LiquiTime refers to an extended release liquid suspension suitable for 12-hour to 24-hour dosing depending upon the application," Flamel CEO Mike Anderson told analysts in August. "We believe LiquiTime will be very attractive to consumers in the OTC market, particularly when compared to liquids that are immediate release and typically have to be dosed every 4 hours to 6 hours," he said.
Development activities for the LiquiTime pipeline include a pivotal trial for LiquiTime ibuprofen in the second half of 2015 and for guaifenesin in the first half of 2016. "Although LiquiTime ibuprofen and LiquiTime guaifenesin can be used as monotherapies, the largest market opportunity in the OTC area exist with cough-cold products that are combinations of expectorants, decongestants, antihistamines, analgesics and cough suppressants," Anderson said.
"This partnership with Flamel on their innovative LiquiTime technology demonstrates our continued focus on the 'Base Plus Plus Plus' strategy," noted Joseph Papa, Perrigo chairman and CEO. During Perrigo's latest conference call with analysts, Papa explained that Perrigo's Base Plus Plus Plus business model endeavors to grow the base business by 5% to 10% while employing Perrigo's expanding platform to drive additional opportunities.
Loading Post Please Wait...